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Orexin neurons play a crucial role in regulating wake-
fulness and energy metabolism, but until recently,
little was known about the factors that influence the
activity of these essential cells. Electrophysiological
studies have now identified positive and negative
feedback signals that allow the orexin neurons to
help maintain wakefulness.
The survival of most animals relies upon maintaining
alertness throughout their active period. When away
from a safe sleeping spot, even a brief nap can be
fatal. Recent electrophysiological studies have begun
to identify how the neuropeptide orexin (also known
as hypocretin) helps maintain wakefulness.
Orexin is produced by lateral hypothalamic neurons,
which project widely throughout the brain, with espe-
cially heavy innervation of aminergic and cholinergic
wake-promoting areas in the hypothalamus and brain-
stem [1–3]. Injection of orexin into the lateral ventricles
increases wakefulness for hours [4,5], most likely
because of its excitatory effects on these arousal
regions. In mice, rats and dogs, a lack of orexin or
dysfunction of the orexin receptors causes nar-
colepsy-like symptoms, such as frequent naps and
sudden episodes of paralysis known as cataplexy
[6–8]. In people with narcolepsy, the number of orexin-
containing neurons is markedly decreased, and they
too have great difficulty remaining awake across the
day [9,10]. These consequences of orexin deficiency
highlight the importance of this peptide in maintaining
normal wakefulness.
Until recently, little was known about the factors that
drive orexin neuron activity, but recent electrophysio-
logical studies have identified several activators and
inhibitors of the orexin neurons. By recording from
hypothalamic slices of transgenic mice expressing
green fluorescent protein (GFP) only in the orexin
neurons, two groups [11,12] have shown that agonists
of ionotropic glutamate receptors (AMPA and NMDA)
excite orexin neurons, whereas glutamate antagonists
(AP-5, CNQX or NBQX ) reduce their activity. This exci-
tation by glutamate persists during synaptic blockade,
demonstrating that glutamate acts directly on the orexin
neurons. These results clearly indicate that orexin
neurons are tonically activated by glutamate, most likely
released by nearby interneurons within the hypothala-
mic slice. Although orexin B peptide has little direct
effect on the activity of orexin neurons, it increases this
glutamate signaling [11]. Thus, neurons containing
orexin and glutamate probably form a positive feedback
loop that may reinforce and coordinate their activity
(Figure 1).
In addition to this feedback loop, orexin neurons may
be spontaneously active by virtue of their membrane
properties. One group [13] found that the resting mem-
brane potential of orexin neurons is close to their
threshold for firing, even during synaptic blockade. This
relative depolarization may be due to a calcium-acti-
vated, nonselective cation current that keeps these
cells near their firing threshold. This propensity for
spontaneous activity may allow the orexin neurons to
remain persistently active, thus helping maintain wake-
fulness over long periods of time.
Wakefulness depends on the coordinated activity of
many neuronal systems. The orexin neurons innervate
and activate aminergic arousal regions such as the
noradrenergic locus coeruleus, serotonergic raphe
nuclei and histaminergic tuberomammillary nucleus [3].
Several researchers have hypothesized that amines
should excite the orexin neurons, forming positive feed-
back loops that would maintain wakefulness [14], but
these new electrophysiological studies show just the
opposite. Both noradrenaline and serotonin hyperpolar-
ize GFP-expressing orexin neurons [11,12]. Histamine
has little effect on orexin neurons, but the histaminergic
tuberomammillary neurons also release GABA [15], and
GABA inhibits the orexin neurons [11–13].
It seems strange that wake-active aminergic areas
would inhibit wake-active orexin neurons. Possibly,
this noradrenaline and serotonin comes from aminer-
gic nuclei other than the locus coeruleus and raphe
nuclei which are not necessarily wake-active. Alterna-
tively, the orexin neurons may become active late
during the waking period, perhaps when aminergic
regions are less active. For example, extracellular
levels of noradrenaline and histamine rise just before
the waking period and then gradually decrease over
the next several hours [16,17]. In contrast, levels of
orexin in rats and monkeys slowly increase across their
waking period [18,19]. Each of these neurotransmitters
may promote different aspects of wakefulness, espe-
cially as recent work indicates that orexin may coun-
terbalance the rising sleep drive later in the day [19]. 
In addition to these synaptic pathways, peripheral
humoral factors related to energy metabolism also
influence orexin neurons. Starvation depletes fat stores
and increases wakefulness in many animals. GFP-
expressing orexin neurons are inhibited by leptin, a
peptide produced by white adipose tissue [20]. During
starvation, the orexin neurons may be disinhibited by
low leptin levels. Conversely, orexin neurons are
excited by ghrelin, a stomach-derived peptide which
promotes feeding, and similar effects are seen with low
levels of glucose [20]. These negative and positive
signals may directly modulate orexin neuron activity
according to appetite and bodily energy stores.
These new studies on the electrophysiology of 
the orexin neurons have substantially improved our
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understanding of the pathways that govern sleep and
wakefulness. Positive feedback loops between orexin
and glutamate neurons as well as a tendency towards
spontaneous activity may allow the orexin neurons to
remain active, even as sleep drive rises over the day.
In addition, the modulation of these neurons by signals
related to appetite and energy balance may help
explain why it is difficult to sleep when hungry. These
properties should allow the orexin neurons to promote
alertness in a hungry animal and maintain long periods
of wakefulness across the day.
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Figure 1. The activity of orexin/hypocretin
neurons is regulated by positive and
negative feedback loops. 
Release of glutamate from hypothalamic
neurons depolarizes orexin neurons
directly. Orexin may activate these gluta-
mate neurons, resulting in a positive feed-
back loop that reinforces their activity.
Sustained activity of orexin neurons may
also result from an intrinsic mechanism
that keeps the orexin neurons relatively
depolarized. Although orexin excites amin-
ergic brain regions, noradrenaline and
serotonin hyperpolarize orexin neurons.
Histaminergic tuberomammillary neurons
might participate in this negative feedback
system by releasing GABA. These nega-
tive feedback loops may allow orexin
neurons and aminergic arousal systems to
be maximally active at separate times.
Peripheral indicators of energy balance,
such as glucose, ghrelin, and leptin, also
directly influence orexin neurons, perhaps
helping promote wakefulness during star-
vation. Red lines, excitatory signaling; blue
lines, inhibitory signaling.
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